872714-60-8Relevant articles and documents
INHIBITORS OF MALT1 AND USES THEREOF
-
Paragraph 00344; 00345, (2018/09/28)
Provided herein are compounds that inhibit MALTl, a protein whose activity is responsible for constitutive NF-κΒ signaling in certain cancers (e.g., activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL)). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating MALTl -related diseases and disorders (e.g., cancer) with the compounds in a subject, by administering the compounds and/or compositions described herein.
ANTIBACTERIAL AGENTS
-
Page/Page column 29, (2010/11/25)
Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
ANTIBACTERIAL AGENTS
-
Page/Page column 20, (2008/06/13)
Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
ANTIBACTERIAL AGENTS
-
Page/Page column 75, (2010/02/15)
Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
ANTIBACTERIAL AGENTS
-
Page/Page column 39, (2010/10/19)
Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.